Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ProSat - Effect of Probiotics on Satiety

This study has been completed.
Sponsor:
Collaborator:
Chr Hansen A/S
Information provided by (Responsible Party):
AAstrup, University of Copenhagen
ClinicalTrials.gov Identifier:
NCT00826761
First received: January 21, 2009
Last updated: June 14, 2012
Last verified: June 2012
  Purpose

The aim of the ProSat study is to examine the effects of a probiotic capsule containing one of two doses (low and high dose) of Lb. Casei on subjective appetite sensation, ad libitum energy intake, and appetite hormone response in a single meal test and to determine whether the acute effects persist after daily supplementation of the probiotic capsule.


Condition Intervention
Obesity
Appetite Regulation
Dietary Supplement: probiotic
Dietary Supplement: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Probiotics and Satiety - Acute Effects and Persistence of Acute Effects

Further study details as provided by University of Copenhagen:

Primary Outcome Measures:
  • Glucose; Insulin; GLP-1; CCK; PYY; grehlin; PP; amylin; LPS; TNF-alfa; hsCRP; fibrinogen [ Time Frame: 2013 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Subjective appetite measurements; Spontaneous food intake [ Time Frame: 2012 ] [ Designated as safety issue: No ]

Enrollment: 22
Study Start Date: January 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
High dose Lb. casei
Dietary Supplement: probiotic
One capsule per meal test (high dose or low dose)
Active Comparator: 2
Low dose Lb. Casei
Dietary Supplement: probiotic
One capsule per meal test (high dose or low dose)
Placebo Comparator: 3 Dietary Supplement: placebo
1 capsuel every morning

  Eligibility

Ages Eligible for Study:   20 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy men and women
  • Normal to slight overweight (BMI: 22-28 kg/m2)
  • 20-45 years of age

Exclusion Criteria:

  • Smoking
  • Daily medicine use (oral contraceptives excluded)
  • Use of pre- and probiotic supplements and foods
  • Blood donation 3 months prior to the study
  • Hb<8mmol/l
  • Chronic illnesses such as hyperlipidemia, diabetes inflammatory diseases
  • Pregnancy or breastfeeding
  • Elite athletes (>10 hours hard exercise/week)
  • Vegetarians
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00826761

Locations
Denmark
Department of Human Nutrition
Frederiksberg, Denmark
Sponsors and Collaborators
University of Copenhagen
Chr Hansen A/S
  More Information

No publications provided

Responsible Party: AAstrup, Professor, University of Copenhagen
ClinicalTrials.gov Identifier: NCT00826761     History of Changes
Other Study ID Numbers: B257
Study First Received: January 21, 2009
Last Updated: June 14, 2012
Health Authority: Denmark: Ethics Committee

ClinicalTrials.gov processed this record on November 19, 2014